Washington Trust’s Ingevity NGVT Stock Holding History

Washington Trust’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50	Closed	-$2K	–	953
2020 Q1	$2K	Buy	+50	New	+$2.92K	﹤0.01%	844
2018 Q3	–	Sell	-3	Closed	–	–	606
2018 Q2	$0	Buy	+3	New	+$238	﹤0.01%	961

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Washington Trust's NGVT Position: Q2 2020 in Review

Washington Trust sold out of Ingevity (NGVT) in Q2 2020, closing a stake of 50 shares — an estimated $2K sold.

Washington Trust first reported a position in NGVT in Q2 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 294 funds tracked by Wall St. Rank hold NGVT as of Q2 2020.

Washington Trust reported no remaining Ingevity position as of Q2 2020 after selling out during the quarter.
Washington Trust sold 50 Ingevity shares in Q2 2020, an estimated $2K.
Washington Trust first reported a position in Ingevity in Q2 2018 and held it in 2 quarters.
Washington Trust's Ingevity position peaked at $2K in Q1 2020.
294 funds tracked by Wall St. Rank held Ingevity as of Q2 2020.

Based on Washington Trust's 13F filing for Q2 2020, filed 4 Aug 2020.